Phase 2WithdrawnINTERVENTIONAL
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
ClinicalTrials.gov · NCT02846857 · Registry updated: 2019-07-23
- Condition / research focus
- Type 1 Diabetes
- Sponsor
- Institut de Recherches Cliniques de Montreal
- Countries with listed sites
- No country reported
- Registry dates and results
- Start: Not reported. Completion: Not reported (may be estimated). No results posted in this registry response.
Products and interventions (7)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- 15-week intervention with sensor-augmented pump (other)
- 15-week intervention with single-hormone closed-loop (other)
- 15-week intervention with dual-hormone closed-loop (other)
- Insulin pump (device)
- Continuous glucose monitoring system (device)
- Insulin (drug)
- Glucagon (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.